Serostim

Serostim (recombinant DNA somatropin) is Serono's brand name prescription drug form of synthetic growth hormone, marketed for AIDS wasting.[1]

In December 2007, the U.S. District Court of Massachusetts settled a class-action lawsuit that involved Merck Serono and the drug Serostim. The lawsuit claims that Merck Serono encouraged doctors to prescribe Serostim off-label for criteria that were not approved by the FDA. Merck Serono denies these claims and any liability. However, Merck Serono has entered into a settlement "solely to avoid the further expense, inconvenience, burden, and uncertainty of these lawsuits."

The settlement will pay consumers of Serostim who paid the full cash amount or a co-payment as part of their medical treatment.

References

  1. ↑ http://www.serostim.com/

External links

http://www.serostimsettlement.com


This article is issued from Wikipedia - version of the 6/11/2015. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.